-
Proteolix, Inc., was a
private biotechnology company with
headquarters in
South San Francisco, California.
Proteolix was
founded in 2003
based on technology...
-
Proteolix, Inc.
Scientists at
Proteolix invented a new,
distinct compound that had
potential use as a drug in humans,
known as carfilzomib.
Proteolix...
-
Medical Institute. He is also the co-founder of the
biotechnology companies Proteolix and
Cleave Biosciences. His
research focuses on
mechanisms and regulation...
-
Poulenc Frères (1827–1928)
PowderJect (1993–2003)
Profound (1999–2008)
Proteolix (2003–2009)
Purdue (1892–2019)
Ranbaxy Laboratories (1961–2014) Reliant...
-
while Kinsella was the firm's chairman. In 2009, the
company acquired Proteolix, Inc., a
private biotechnology company, for $276
million in cash plus...
- Ross Stores, Ask Jeeves, Adify, PetSmart,
Check Point, Mellanox, Vontu,
Proteolix, Dotomi, Imperva,
Guidewire Software, Yammer, Trusteer,
Nanostim and Trunk...
- an
orally active second-generation
proteasome inhibitor developed by
Proteolix,
which was
acquired by Onyx Pharmaceuticals, an
Amgen subsidiary, in 2009...
- inhibitor, YU101. In 2003,
Crews co-founded the
biotechnology company Proteolix to
develop YU101,
which ultimately served as the
parent compound of multiple...
-
trials with
industry partners –
including Novartis, Celgene, Merck, and
Proteolix. MMRC
clinical trials are also
designed to
include correlative studies...
